Upsher-Smith launches new website for Qudexy XR
MAPLE GROVE, Minn. — Upsher-Smith Laboratories on Monday announced the launch of its enhanced website for Qudexy XR (topiramate) extended-release capsules.
The site features Upsher-Smith’s Access Pathways Program designed to reduce the barriers associated with prescribing the medication and offers healthcare professionals the tools they need to help patients start Qudexy XR therapy, the company said. These tools include an informational video, a guide on how to get started and a patient enrollment form. In addition to being indicated to treat certain types of seizures, Qudexy XR is now indicated for use in the prevention of migraine headache in adults and adolescents 12 years of age or older.
“Upsher-Smith understands that access and affordability for extended-release brand products can be a challenge for patients and an administrative hurdle for physician offices,” said Rusty Field, president and CEO, Upsher-Smith. “The updated website offers resources that will allow them to prescribe Qudexy XR with greater ease.”
Eligible patients enrolled in the Access Pathways Program will receive a $0 co-pay offer. Patients paying cash or those who many not have insurance will benefit from a low-cost option, according to the company. The program also offers:
- Benefit verification
- Prior authorization support
- E-voucher pharmacy finder
- Pharmacy stocking assistance
Click here for more information on Qudexy XR.
NACDS, coalition ads thank legislators for backing pro-patient, pro-pharmacy bill
In newspaper ads placed in selected Congressional districts this August, NACDS is thanking members of the U.S. House of Representatives for co-sponsoring the Pharmacy and Medically Underserved Areas Enhancement Act (H.R. 592/S. 109). NACDS also is urging the members of Congress to work toward ultimate passage and enactment of the legislation.
The bill would allow people covered by Medicare to obtain basic healthcare services from their pharmacists. It would apply to those who are considered to have fewer healthcare access solutions than most, and to services that pharmacists are allowed to perform under state laws. Related services could include basic health tests, immunizations, tests for flu or strep throat and help with managing such chronic illnesses as diabetes. Medicare beneficiaries already can receive such services from nurse practitioners and physician assistants. NACDS emphasizes that pharmacists are highly qualified to provide many services beyond medication dispensing by virtue of the minimum six-year doctor of pharmacy degree that is required to sit for the pharmacy license exam.
In the ads, NACDS highlights the popularity of the concept behind the bill, based on opinion research conducted by Morning Consult and commissioned by NACDS. This research also was the basis for a new NACDS opinion research dashboard, which was released earlier this year. The research’s results can be reported at the state and Congressional district levels. Roughly 8-in-10 respondents support the ability of Medicare patients to obtain various healthcare services from pharmacists. Notably, support for this concept runs equally strong among those who voted for President Donald Trump, those who voted for Hillary Clinton and those who voted for another candidate in the 2016 presidential election.
NACDS’ print ads complement similar radio and digital ads by the Patient Access to Pharmacists’ Care Coalition, or PAPCC, which also are appearing in selected Congressional districts this August. NACDS is a Steering Committee member of PAPCC.
Mission Pharmacal extends product lines
Drug Store News recently spoke with Phillip Dritsas, SVP and general manager, consumer division and specialty markets for Mission Pharmacal, about the opportunities for Dr. Smith’s products in both the baby and adult categories.
DSN: Can you tell us more about trends in both ends of the baby and adult category?
Phillip Dritsas: [According to] IRI data, the baby category seems to be stable, but expanding with respect to new players entering the category. The good news for Dr. Smith’s Diaper Rash Ointment and Spray is that we’re seeing growth that is outpacing the category performance. We have enjoyed bringing new innovation for parents with our “touch-free” spray. The convenience and effectiveness, coupled with the environmentally friendly qualities of the product, are faring well with our consumers.
In the adult incontinence category, we see great opportunity with the recent introduction of the Dr. Smith’s Adult Barrier Spray 3.5-oz. product. Retailers — and customers — see the unique propositions of the touch-free, zinc oxide spray product when it comes to caregivers. This category is about providing loved ones with dignity and compassion in the treatment of rashes and chafing due to adult incontinence. Dr. Smith’s Adult Barrier Spray provides customers with a new product to help make their role as caregiver a little easier. Additionally, offering a barrier product in the adult incontinence aisle alleviates the need for the consumer to then go to the baby section to shop for their adult incontinence product needs.
Mission Pharmacal’s most recent consumer offering is a new head lice product, Lycelle. Lycelle is gaining significant retail space, and the product is resonating with school nurses, pharmacists and consumers who prefer a pesticide-free lice elimination product that works in a single application.
DSN: Do you see more growth in the usage of the adult rash product, or is it fairly even?
Dritsas: We see a strong opportunity in the adult incontinence category. The sheer volume of people in the adult and senior demographic who are in nursing homes, and those caring for aging parents, reinforces that there is a market and, more importantly, a need for a product like Dr. Smith’s Adult Barrier Spray. Offering a touch-free, zinc oxide solution for those individuals through the retailer or institutional side certainly presents significant opportunity for the brand.
DSN: Is the moisture-sealed technology driving this growth?
Dritsas: When it comes to baby diaper rash, or rashes [and] chafing due to adult incontinence, offering a moisture-shield technology is important in our Dr. Smith’s line of products. You certainly want a product that is effective in providing a strong moisture barrier for both prevention and treatment. Another driving force in our growth is the GreenTek Spray System that offers ease and convenience when dealing with baby or adult rashes. Mission Pharmacal has partnered with Honeywell to deliver this proprietary and patented technology that allows for ease of use without sacrificing its environmental integrity.
DSN: How is your #ReachfortheDoctor social media campaign helping to drive business to retail and reach key influencers?
Dritsas: Social media continues to play a big part in the success and ongoing growth of the Dr. Smith’s baby brand. As social media evolves daily, our social and digital marketing efforts continue to expand in this space. Social media and influencers are important in driving business to retail because moms are always looking to reviews and advice from friends and family before they purchase a product for their baby. They want to be sure that what they are putting on their baby is the best product possible, and that it works — fast. As much as we believe in our product, it’s even more important for moms and dads to hear from other moms and dads about how our product works. Consumers don’t want to hear from the brand about how great their products are. They have to hear it from peers. Social media provides the platform for this feedback.